Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240

The functional anatomy of basal ganglia disorders

Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

Betarbet, R. S., Sherer, T., MacKenzie, G. M., Garcia‐Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,770

Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator

West, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994

Some new, simple and efficient stereological methods and their use in pathological research and diagnosis.

GUNDERSEN, H. J. G., BENDTSEN, T. F., KORBO, L., MARCUSSEN, N., MØLLER, A., NIELSEN, K., NYENGAARD, J. R., PAKKENBERG, B., SØRENSEN, F. B., VESTERBY, A., et al. (1988) · APMIS · doi:10.1111/j.1699-0463.1988.tb05320.x · Cited by 2,929

Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease

Paisán‐Ruiz, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munaín, A. L., Aparicio, S. F., Gil, A. M., Khan, N. L., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,453

α-Synuclein is phosphorylated in synucleinopathy lesions

Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,174

Oxidative stress in Parkinson's disease

Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053

Recent perspectives in neurology

Ziemssen, T., & Storch, A. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1068-z · Cited by 4

Gut bacteria composition in animal models of Parkinson’s disease: a systematic review and meta-analysis

Elford, J. D., Heesbeen, E. J., van der Plaats, N. A., Garssen, J., Kraneveld, A. D., Groenink, L., & Perez‐Pardo, P. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-025-01236-0 · Cited by 2

The Gut-Brain Axis: A Critical Link between Type 2 Diabetes and Parkinson’s disease

Almohmadi, N. H., Al‐kuraishy, H. M., Hussein, K. S., Turkistani, A., Yousef, F. M., Al-Gareeb, A. I., Abdelaziz, A. M., Elewa, Y. H. A., & Batiha, G. E. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11014-w · Cited by 2

Animal models of central nervous system disorders

Gomes, E. D., Barata‐Antunes, S., Teixeira‐Castro, A., Assunção-Silva, R. C., Marques, C. R., Monteiro, S., Teixeira, F. G., Fernandes, A. M., & Silva, N. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818084-6.00018-0 · Cited by 3

Linking copper and neurotoxic activities to the CNS

Santos, G., Ávila-Rodriguez, M., Rubio, É. P., Galembeck, E., & Borges, J. M. P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89835-5.00035-1 · Cited by 2

Comprehensive review of in vitro gut-brain axis models in Parkinson’s disease research

Cauba, J. N., Woo, J., Wiggins, R. W., & Mito, S. (2025) · Brain Organoid and Systems Neuroscience Journal · doi:10.1016/j.bosn.2025.03.002 · Cited by 2

Ultrasonography of the vagus nerve in Parkinson’s disease: a systematic review and meta-analysis

Cui, Y., Yan, R., Qu, Y., Liu, S., & Li, X. C. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08346-w · Cited by 2

Neurovascular Interface in Porcine Small Intestine: Specific for Nitrergic rather than Nonnitrergic Neurons

Jabari, S., Neuhuber, W., & Brehmer, A. (2016) · Cells Tissues Organs · doi:10.1159/000444168 · Cited by 2

Acute Exposure to the Food-Borne Pathogen Listeria monocytogenes Does Not Induce α-Synuclein Pathology in the Colonic ENS of Nonhuman Primates

Mancinelli, A. M., Vichich, J. M., Zinnen, A. D., Hugon, A. M., Bondarenko, V., Metzger, J. M., Simmons, H. A., Golos, T. G., & Emborg, M. E. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s337549 · Cited by 2

Posible contribución del paraquat al desarrollo de la enfermedad de Parkinson

Elena‐Real, C. A., Pasión-Galván, R., Pérez-Artés, M. R., Rodríguez, M. P., & Navarro, I. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2

Reconciling Braak’s model of Parkinson’s disease with a prion-like spread of alpha synuclein pathology

Brooks, P. L., Visanji, N. P., Hazrati, L., & Lang, A. E. (2012) · Basal Ganglia · doi:10.1016/j.baga.2012.05.004 · Cited by 2

Finding gaps and building bridges in movement disorders

Fasano, A. A., Espay, A. J., & Morgante, F. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.58 · Cited by 2

Gastrectomy and nigrostriatal dopaminergic depletion in de novo Parkinson's disease

Chung, S. J., Jeon, S., Yoo, H. S., Yoon, J. H., Lee, J. E., Kim, J., Kim, S., Oh, J. S., Kim, J. S., Ye, B. S., et al. (2018) · Movement Disorders · doi:10.1002/mds.27580 · Cited by 2

The relationship between inflammatory bowel disease and Parkinson’s disease: true or fiction?

Carmona‐Abellán, M., Rodríguez–Lago, I., Cabriada, J. L., & Gómez‐Esteban, J. C. (2019) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2019.1641739 · Cited by 2

Role of the Gut Microbiome and Bacterial Amyloids in the Development of Synucleinopathies

Trubitsina, N. P., Matiiv, A. B., Rogoza, T. M., Zudilova, A. A., Bezgina, M. D., Zhouravleva, G. A., & Bondarev, S. A. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924030118 · Cited by 2

Hypothesis of Ascension in Idiopathic Parkinson’s Disease

Klingelhoefer, L., & Reichmann, H. (2017) · Neurology International Open · doi:10.1055/s-0043-102389 · Cited by 1

Gastrointestinal Disturbances in Parkinson’s Disease Including the Management of Sialorrhea

Jost, W. H., & Klingelhoefer, L. (2022) · Cambridge University Press eBooks · doi:10.1017/9781009039291.014 · Cited by 1

Correlation between α-synuclein and fatty acid composition in jejunum of rotenone-treated mice is dependent on acyl chain length

Hajdúchová, D., Holič, R., Gajdoš, P., Čertí­k, M., Halášová, E., Péčová, R., & Pokusa, M. (2022) · General Physiology and Biophysics · doi:10.4149/gpb_2022046 · Cited by 1

The Enigmatic Gut-Brain-Immune Trio in Brain and Behavior Disorders

Mythri, R. B. (2025) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-7432-0.ch019 · Cited by 1

Understanding the Pre-Clinical Stages of Parkinson’s Disease: Where Are We in Clinical and Research Settings?

Verde, C. D., Jayanti, S. D., El-Khobar, K. E., Stanford, J. A., Tiribelli, C., & Gazzin, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146881 · Cited by 3

Early alpha-synuclein accumulation, oxidative stress and inflammation in the proximal colon of c-rel-/- mouse model of Parkinson's disease

Parrella, E., Gennari, M. M., Abate, G., Pucci, M., Schioppa, T., Bosisio, D., Tirelli, E., Benarese, M., Vegezzi, G., Silletti, M., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107182 · Cited by 2

Enteric Nervous System Damage by Food Contaminants: A Pathway to Neurodegeneration?

Ramos, H., Araújo, A. M., Ferreira, I. M. P. L. V. O., & Faria, M. Â. (2026) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.70448 · Cited by 1

The inherent susceptibility of dorsal motor nucleus cholinergic neurons to the neurodegenerative process in Parkinson's Disease

McCarthy, A., McKinley, J., & Lynch, T. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2012.00189 · Cited by 1

Pathogenesis of movement disorders: basic neuroanatomy and pathophysiology

Pauls, K. A. M., & Timmermann, L. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175845.003 · Cited by 1

Mitocans, Mitochondria-Targeting Anticancer Drugs

Neužil, J., Dong, L., & Rohlena, J. (2012) · Oxidative stress and disease · doi:10.1201/b12308-6 · Cited by 1

The Rotenone Model of Parkinson's Disease in Studying the Mechanisms of Nigrostriatal Cell Death

Abdel‐Salam, O. M. E. (2015) · Cited by 1

La maladie de Parkinson est aussi une maladie du tube digestif

Derkinderen, P. (2019) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2019.11.013 · Cited by 1

The role of environmental toxins and inflammation in Parkinson's disease pathophysiology: a historical perspective and research-based evidence

Pan-Montojo, F. J., Loewenbrück, K. F., & Reichmann, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815946-0.00003-x · Cited by 1

Spreading of alpha-synuclein pathology from the gut to the brain in Parkinson's disease

Jevans, B., & Monte, D. A. D. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.08.004 · Cited by 1

Gut Microbiota Changes and Parkinson’s Disease: What Do We Know, Which Avenues Ahead

Hirayama, M., & Ohno, K. (2023) · Healthy ageing and longevity · doi:10.1007/978-3-031-14023-5_13 · Cited by 1

Parkinson's disease: A Review about Pathogenesis, Pharmaceutical Treatment and Experimental Models

El-Sayed, E. K., Eissa, A. A., Nofal, S., & Morsy, E. M. E. (2018) · Journal of Advanced Pharmacy Research · doi:10.21608/aprh.2018.8013 · Cited by 1

Gut and Parkinson’s disease

Ovallath, S., & Sulthana, B. (2018) · Annals of Movement Disorders · doi:10.4103/aomd.aomd_4_18 · Cited by 1

Vagal motoneurons in Parkinson's disease

Musgrove, R. E., Chiu, W., & Goldberg, J. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815950-7.00021-7 · Cited by 1

Relação entre a exposição ao pesticida Rotenona e o desenvolvimento de sintomas motores e não-motores da doença de Parkinson

de Oliveira, J. K. S., de Carvalho, J. M., Silva, C. A., de Lima, M. B., Cavalcante, P. M. F., & Paiva, D. F. F. (2020) · Research Society and Development · doi:10.33448/rsd-v9i9.7917 · Cited by 1

ROLE OF GDNF AND ITS CROSS-TALK WITH OTHER GROWTH FACTORS IN THE DOPAMINERGIC SYSTEM

Planken, A. (2012) · Työväentutkimus Vuosikirja · Cited by 1

Creating a protein-protein interaction network for alpha-synuclein

Könn, M. (2012) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-7491 · Cited by 1

Physiological and pathological changes in the enteric nervous system of rotenone-exposed mice as early biomarkers for Parkinson’s diseasePreprint

Schaffernicht, G., Shang, Q., Stiévenard, A., Bötzel, K., Dening, Y., Kempe, R., Toussaint, M., Gündel, D., Kranz, M., Reichmann, H., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.11.421164 · Cited by 1

Amelioration of depressive symptoms on Fawn-Hooded rats through the ‘healthy’ fecal microbiota transplantationPreprint

Hu, B., Das, P., Lv, X., Shi, M., Aa, J., Wang, K., Duan, L., Gilbert, J. A., Nie, Y., & Wu, X. (2021) · Research Square · doi:10.21203/rs.3.rs-917357/v1 · Cited by 1

Parkinson's Disease

Goldman, S. M. (2013) · Wiley eBooks · doi:10.1002/9781118679654.ch18 · Cited by 1

α-Synuclein Oligomers Induce the Loss of Dopaminergic Neurons via Mitochondrial Dysfunction and Oxidative Stress in an Intragastric Rotenone Mouse Model of Parkinson’s DiseasePreprint

Huang, T., Liang, Q., Hong, M., Huang, M., Uversky, V. N., Pan-Montojo, F. J., Jiang, H., Chen, J., Zhou, H.-L., & Hu, Q. Z. (2022) · Research Square · doi:10.21203/rs.3.rs-1371254/v1 · Cited by 1

Influence of Diphenyl Diselenide on Thiol Redox Homeostasis and Electrogenic Membrane Transport in Rotenone-Induced Parkinson’s DiseasePreprint

Ologunagba, T. I., Olorundare, B. O., Iyanda, T. A., Adewole, M. A., & Kade, I. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.30.514424 · Cited by 1

Intragastric administration of low-dose rotenone post-colitis exacerbates damage to the nigrostriatal dopaminergic system in Parkinson’s disease: The pace accelerates even morePreprint

Sharma, N., Sharma, M., Thakkar, D., Kumar, H., Smetanová, S., Burešová, L., Andrla, P., & Khairnar, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.22.521569 · Cited by 1

The public health environment and brain function

Doyle, S. J., Rostamihosseinkhani, M., & Sabayan, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-820480-1.00163-7 · Cited by 1

Movement Disorders: Parkinson's Disease

Homayoun, H., & Goetz, C. G. (2014) · Methods and principles in medicinal chemistry · doi:10.1002/9783527679348.ch18

The Pitx3-deficient aphakia mouse: a naturally occurring mouse model of dopamine deficiency

van den Munckhof, P. (2011) · UvA-DARE (University of Amsterdam)

Role of Trichloroethylene in Parkinson’s Disease

Goldman, S. M., & Cash, S. W. (2014) · Molecular and integrative toxicology · doi:10.1007/978-1-4471-6311-4_6

Tiermodelle der REM-Schlaf-Verhaltensstörung

Krenzer, M., Depboylu, C., Lu, J., & Oertel, W. H. (2014) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1007/s11818-014-0677-6

Researchers unite to improve Parkinson's drug discovery

Dolgin, E. (2010) · Nature Medicine · doi:10.1038/nm0310-247b

Overview of Parkinson's Disease: Examing the role for the Gut-Brain-Gut axis and the use of Nutrients based on preclinical and clinical evidence

Koopman, H. J. M. (2013) · Utrecht University Repository (Utrecht University)

The Effects of Prolyl Oligopeptidase Inhibition in α-Synuclein Based Mouse Models of Parkinson's Disease

Savolainen, M. H. (2015) · Työväentutkimus Vuosikirja

Loss of Mortalin Function in Parkinson’s Disease-Supporting the Mitochondrial Pathway of Neurodegeneration

Burbulla, L. F., & Krüger, R. (2012) · Springer eBooks · doi:10.1007/978-94-007-3027-4_10

Parkinson fängt im Darm an

Reichmann, H., & Baas, H. K. J. (2015) · DNP - Der Neurologe und Psychiater · doi:10.1007/s15202-015-0813-6

Evaluation of metallothionein involvement in the modulation of mitochondrial respiration in mice

Pretorius, M. (2011) · Boloka Institutional Repository (North-west University)

Die Rolle von Neuromelanin in der Pathogenese desidiopathischen Parkinson Syndroms

Geick, S. (2011) · Multimedialen Archiv und Publikationsserver der Christian-Albrechts-Universität zu Kiel (Christian-Albrechts-Universität zu Kiel)

Animal Models in Neuro Ophthalmology

Normando, E. M., Brodie, J. T., & Cordeiro, M. F. (2016) · Springer eBooks · doi:10.1007/978-3-319-24085-5_13

Considerations on the role of environmental toxins in idiopathic Parkinson's disease

Pan-Montojo, F. J., & Reichmann, H. (2014)

The non-motor complications in Parkinson's disease - what can we learn from animal models?

Kurnik‐Łucka, M., & Thor, P. J. (2015) · PubMed

Neue Medikamente zur Behandlung des idiopathischen Parkinson-Syndroms

Reichmann, H. (2016) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-016-1779-4

Muss die bisherige BfR-Stellungnahme zur Risikobewertung revidiert werden?

Kuhn, W., Gerlach, M., & Müller, T. H. (2016) · NeuroTransmitter · doi:10.1007/s15016-016-5640-2

Überblick über den aktuellen Stand einer möglichen Assoziation zwischen Rotenon-Exposition und einer parkinsonoiden Erkrankung

Bundschuh, M., & Klingelhöfer, D. (2013) · Zentralblatt für Arbeitsmedizin Arbeitsschutz und Ergonomie · doi:10.1007/bf03346186

The Non-motor Parkinson’s Disease

Sauerbier, A., Klingelhoefer, L., Qamar, M. A., Carr, H. J., & Chaudhuri, К. R. (2017) · Springer eBooks · doi:10.1007/978-3-7091-1628-9_12

A reaction-diffusion model for the progression of Parkinson's diseasePreprint

Garcia, M. R., Cloutier, M., & Wellstead, P. E. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1702.05259

Aszensionshypothese beim idiopathischen Parkinson-Syndrom

Klingelhoefer, L., & Reichmann, H. (2017) · Aktuelle Neurologie · doi:10.1055/s-0043-101907 · Cited by 1

Identification and Analysis of Gene Product Modifiers of α-Synuclein Toxicity in the Fruit Fly (D. Melanogaster).

Butler, E. K. (2010) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3186

Der Gastrointestinaltrakt rückt ins Zentrum

Schneider, S. A., & Deuschl, G. (2015) · NeuroTransmitter · doi:10.1007/s15016-015-0671-7

Need for more holistic therapeutic and management strategies to understand the causal or correlative link of the Aβ amyloid pathway with Alzheimer’s disease for a more efficiënt treatment

Timmermans, J. (2018) · Peptides · doi:10.1016/j.peptides.2018.03.002

Cell Therapy for Parkinson’s Disease

Chen, Z. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00049-x

Die Beteiligung des enterischen Nervensystems bei Morbus Parkinson

Woitalla, D. (2018) · NeuroTransmitter · doi:10.1007/s15016-018-6213-3

Influence of Dietary Constituents on Motor and Non-motor Symptoms in Parkinson’s Disease

Löhle, M., & Reichmann, H. (2014) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-09537-0_5

Investigating early functional alteration in a human iPSC-based model of Parkinson’s Disease

Carola, G. (2019) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)

Parkinsonian Toxins: From MPTP to Endogenous Neurotoxins

Naoi, M., Maruyama, W., & Shamoto‐Nagai, M. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_359-1

Microbiota and Parkinson's disease (overview)

Tyutina, R. R., Pilipovich, A. A., Голубев, В. Л., & Danilov, A. B. (2020) · Medical alphabet · doi:10.33667/2078-5631-2020-1-10-14 · Cited by 1

Assessment of Nonmotor Symptoms in Rodent Models of Parkinson’s Disease

Rossi, F., Carta, M., & Tronci, E. (2020) · Neuromethods · doi:10.1007/978-1-0716-0912-5_2

Activation of Astrocytes in Neurodegenerative Diseases

Li, J., & Qin, S. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_3

Validation of Diffusion Kurtosis as an Early-Stage Biomarker of Parkinson’s in Animal Models

Khairnar, A., Dražanová, E., Szabó, N., & Ruda-Kucerova, J. (2021) · Neurodegenerative Diseases Biomarkers · doi:10.1007/978-1-0716-1712-0_18

Age-dependent Effect Imposed by Rotenone ExposurePreprint

Moseley, M. C., Rawls, A., Sponsel, V. M., Berger, M. S., Abate, A. R., & Lin, C. A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.01.466812

Faculty Opinions recommendation of Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease.

Cai, D. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736045520.793566639

The effect of opioid abuse on HIV infected nervous system

Lu, T., & Wang, K. (2020) · Ibrain · doi:10.1002/j.2769-2795.2020.tb00051.x · Cited by 1

Animal Models in Neuro Ophthalmology

Normando, E. M., & Cordeiro, M. F. (2020) · Springer eBooks · doi:10.1007/978-3-030-26269-3_19

Animal models of Parkinson’s disease and related disorders

Petzinger, G. M., & Jakowec, M. W. (2013) · Informa Healthcare eBooks · doi:10.3109/9781841849096.014

Modelling motor and non-motor signs of early-stage Parkinson's disease

Ivanov, M. V., & Kutukova, K. A. (2022) · Annals of Clinical and Experimental Neurology · doi:10.54101/acen.2022.2.6

α-Synuclein oligomers induce the loss of dopaminergic neurons via mitochondrial dysfunction and oxidative stress in an intragastric rotenone mouse model of Parkinson’s diseasePreprint

Huang, T., Chen, J., Hong, M., Huang, M., Jiang, H., Zhou, H., Zhu, S., & Hu, Q. Z. (2022) · Research Square · doi:10.21203/rs.3.rs-1371254/v2

A comparative study of neurobehavioral changes induced by rotenone through oral and intraperitoneal administration

Kavuri, S., & Sivanesan, S. (2022) · International Journal of Research in Pharmaceutical Sciences · doi:10.26452/ijrps.v13i4.3404

Parkinsonian Toxins: From MPTP to Endogenous Neurotoxins

Naoi, M., Maruyama, W., & Nagai, M. S. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_359

Exosomes as mediators of chemical-induced toxicity

Polaka, S., Tekade, M., Vasdev, N., Gupta, T., Pawar, B., Safavi, M., & Tekade, R. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15840-7.00007-5

Pharmacognostic specification and rotenone content in derris elliptica stems, macroscopic, microscopic and molecular identification of selected derris species in Thailand

Phairoh, K. (2020) · doi:10.58837/chula.the.2020.421

Rotenone

Khayatan, D., Khanahmadi, M., Zare, K., Shalmani, L. M., Momtaz, S., & Abdolghaffari, A. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824315-2.00895-2

Fields and Exposure Periods

Ishido, M. (2023) · Springer eBooks · doi:10.1007/978-981-99-1560-6_9

The establishment and application of animal models for neurodegenerative diseases

Pan, J., Zhang, L., Wang, Q., Zhao, D., Huang, Z., Wei, C., Ma, X., & Qin, C. L. (2023) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-0764

Nocardia cyriacigeorgica Elicits Gut Disturbances in a Leaky Gut Model of Colitis, but Not the Harmful Cascade Leading to Gut-First Parkinson’s Disease

Magalhães, J. D., Candeias, E., Melo-Marques, I., Abreu, A. E., Pereira-Santos, A. R., Esteves, A. R., Cardoso, S. M., & Empadinhas, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063423

Role of the Gut Microbiome and Bacterial Amyloids in the Development of Synucleinopathies (Review)

Trubitsina, N. P., Matiiv, A. B., Rogoza, T. M., Zudilova, A. A., Bezgina, M. D., Zhouravleva, G. A., & Bondarev, S. A. (2024) · Biochemistry (Moscow) · doi:10.31857/s0320972524030089

Facets of movement disorders– a tribute to Heinz Reichmann

Riederer, P. F., & Hirsch, É. C. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02857-0

Movement disorders related to drugs and toxins

Aldaajani, Z., Badawi, M. A., & Obaid, M. T. (2024) · International review of movement disorders · doi:10.1016/bs.irmvd.2024.09.008

Effectiveness of aerobic exercise interventions on balance, gait, functional mobility and quality of life in Parkinson’s disease: an umbrella review

Yildirim, M. C., Ekici, H. S., Collins, J., Piasecki, J., Skelly, R., Gordon, A. L., & Phillips, B. E. (2024) · Translational Exercise Biomedicine · doi:10.1515/teb-2024-0031

Systemic exposure to rotenone toxicity induces gastro-inflammatory damage in mice: protective response of Zingiber officinale Roscoe extract

Adebayo, O. G., Modo, E. U., Orji, B. O., Chimezie, J., Wopara, I., Masanwoola, A. V., Ichipi-Ifukor, P. C., Oritsemuelebi, B., & Esezobor, K. I. (2025) · Nutrire · doi:10.1186/s41110-025-00321-x

Mitochondrial toxicants to model Parkinson’s disease

Currim, F., & Cannon, J. R. (2025) · Advances in neurotoxicology · doi:10.1016/bs.ant.2025.02.005

Comparison of the antiparkinsonian activity of N-decyltropine (IEM-1556) and levodopa in rats with rotenone-induced parkinsonism

Гмиро, В. Е., Serdyuk, S. E., & Shabanov, P. D. (2025) · Психофармакология и биологическая наркология · doi:10.17816/phbn653995

Animal Models in Neuro Ophthalmology

Normando, E. M., Sher, A., Patel, R. P., Arora, N., & Cordeiro, M. F. (2025) · Springer eBooks · doi:10.1007/978-3-031-72156-4_19

Parkinson-Krankheit – nicht-motorische Symptome für die Praxis

Jost, W. H. (2025) · Neurologie up2date · doi:10.1055/a-2565-7885

The Effects of Vortioxetine on Rotenone-Induced Inflammatory Changes in Rat-Derived Enteroglial Cells: The Role of the TLR4/NFκB Signaling Pathway

Samur, D. N., Maytalman, E., & Zorlu, Ö. (2025) · OSMANGAZİ JOURNAL OF MEDICINE · doi:10.20515/otd.1672924

Title Progression of Parkinson’s disease pathology is reproduced by intragastric administration of rotenone in mice Authors and Affiliations

Pan-montojo, F., Anichtchik, O. V., Dening, Y., Knels, L., Gille, G., Spillantini, M. G., Reichmann, H., Funk, R. H. W., Fakultät, M., Carus, C. G., et al. (2016)

Oral Administration of Rotenone using a Gavage and Image Analysis of Alpha-synuclein Inclusions in the Enteric Nervous System

Pan-Montojo, F. J., & Funk, R. H. W. (2010) · Journal of Visualized Experiments · doi:10.3791/2123 · Cited by 33

Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology

Drolet, R. E., Cannon, J. R., Montero, L. M., & Greenamyre, J. T. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.017 · Cited by 262

Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice

Pan-Montojo, F., Schwarz, M., Winkler, C., Arnhold, M., O'Sullivan, G. A., Pal, A., Said, J., Marsico, G., Verbavatz, J.-M., Rodrigo-Angulo, M., et al. (2012) · Scientific Reports · doi:10.1038/srep00898 · Cited by 405

Environment-contact administration of rotenone: A new rodent model of Parkinson’s disease

Liu, Y., Sun, J., Song, L.-K., Li, J., Chu, S., Yuan, Y., & Chen, N. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.07.058 · Cited by 69